The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 54.80
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.40 (0.733%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 54.80
AXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

21 Sep 2017 07:00

RNS Number : 3542R
Accsys Technologies PLC
21 September 2017
 

 

AIM: AXS

Euronext Amsterdam: AXS

21 September 2017

 

ACCSYS TECHNOLOGIES PLC("Accsys" or "the Company")

 

Annual General Meeting Statement

 

Accsys, the chemical technology group, focused on the highly sustainable acetylation of wood, today announces that in advance of its Annual General Meeting, to be held at 2.30 p.m. (UK time) this afternoon, its Chief Executive, Paul Clegg, has made the following comments:

 

"I am pleased to report sales of Accoya increased by 20% in the five months to 31 August 2017 compared to the same period last year, with Accoya revenue of €22.5m (2016: €18.7m) (unaudited). This represented 16,970 cubic metres of Accoya sold (2016: 14,187 cubic metres).

 

Demand continues to be strong, however as previously stated we are now operating at full capacity. Further growth will therefore be constrained until the third reactor is complete and we are working with our customers in order to minimise the impact of this temporary capacity limitation.

 

Work in respect of the first phase of the expansion of the Arnhem plant is progressing well. Full commissioning of the third reactor is expected later this financial year and the benefit of the new capacity continues to be expected to be available from the start of the new financial year enabling further significant growth in sales and production.

 

This will increase our Accoya production capacity to approximately 60,000 cubic metres, representing a significant increase compared to the 31,532 cubic metres of Accoya sold in the last financial year (excluding material sold to Medite for Tricoya, which will be supplied by the Tricoya plant in Hull following its completion in 2019).

 

Production of Accoya decreased marginally to 16,124 cubic metres for the five months to 31 August 2017 (2016: 16,220 cubic metres). Production was impacted in May by a one-off shut down relating to the expansion project with some associated costs and which was slightly longer than expected. Raw material costs have increased in the four months to 31 August 2017 compared to last year and we are currently reviewing the implementation of a price increase.

 

Next week we look forward to hosting the majority of our customers in Arnhem for our global Accoya sales conference where we will be focussing on the continued growth of Accoya given the imminent completion of the capacity expansion and the increasing demand for our products.

 

Following the formation of the Tricoya consortium with BP, Medite and our financial partners BGF and Volantis, I am also pleased to report excellent progress with construction of the world's first dedicated chip acetylation plant in Hull for the manufacture of Tricoya. Extensive ground works including piling, have commenced on site together with detailed engineering being undertaken by Engie Fabricom and a focus on procurement of key items of equipment."

 

Our interim financial statements for the six months ended 30 September 2017 are expected to be released on 22 November 2017.

 

Ends

 

For further information, please contact:

 

Accsys Technologies PLC

Paul Clegg, CEO

Will Rudge, FD

Hans Pauli, Executive Director, Corporate

Development

via MHP Communications

Numis Securities

Nominated Adviser: Oliver Cardigan

Jamie Lillywhite

Corporate Broking: Christopher Wilkinson

Ben Stoop

+44 (0) 20 7260 1000

 

MHP Communications

Tim Rowntree

Kelsey Traynor

+44 (0) 20 3128 8100

 

Off the Grid (The Netherlands)

Frank Neervoort

Yvonne Derske

+31 681 734 236

+31 222 379 666

 

 

 

 

Notes to editors:

 

Accsys Technologies PLC (www.accsysplc.com) is a chemical technology group whose primary focus is on the production of Accoya® wood and technology licensing via its subsidiary, Titan Wood Limited, which has manufacturing operations in Arnhem, the Netherlands (through its subsidiary Titan Wood B.V.), a European office in London, United Kingdom, an American office in Dallas, Texas (via its subsidiary Titan Wood, Inc) and technology licencing associated with the acetylation of wood elements via its subsidiary Tricoya Technologies Limited. Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. Accsys Technologies PLC is listed on the London Stock Exchange AIM market and on Euronext Amsterdam, under the symbols 'AXS'. Accsys' operations comprise three principal business units: (i) Accoya® wood production; (ii) technology development, focused on a programme of continuous development of and improvements to the process engineering and operating protocols for the acetylation of solid wood and the development of technology for the acetylation of wood elements; and (iii) the licensing of technology for the production of Accoya® wood and Tricoya® wood elements across the globe.

Accoya® wood (www.accoya.com) is produced using Accsys' proprietary patented acetylation technology that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "high technology wood". Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Unlike most tropical and European hardwoods, its colour does not degrade when exposed to ultraviolet light. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of UV resistance, dimensional stability, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. These benefits result in lower maintenance and total cost of ownership while using a higher sustainable and environmental responsible building material. For a full archive of Accoya® news, visit www.accoya.com/news.asp.

Tricoya® Wood Elements (www.tricoya.com) are produced using Accsys' proprietary technology for the acetylation of wood chips, and particles for use in the fabrication of panel products such as medium density fibreboard and particle-board. These products demonstrate enhanced durability and dimensional stability which allow them to be used in a variety of applications that were once limited to solid wood or man-made products. Exploitation of Accsys' proprietary technology relating to Tricoya® Wood Elements is carried out through Tricoya Technologies Limited. Tricoya® Wood Elements are lauded as the first major innovation in the wood composites industry in more than 30 years.

Wood Acetylation is a process which increases the amount of 'acetyl' molecules in wood, thereby changing its physical properties. When carried out to a sufficient level throughout the wood, this process protects wood from rot by making it "inedible" to most micro-organisms and fungi, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that, when painted, it requires dramatically reduced maintenance.

 

 

Accsys Technologies is the trading name of Titan Wood Limited. ACCOYA®, TRICOYA® and the Trimarque Device are registered trademarks owned by Titan Wood Limited ("TWL"), a wholly owned subsidiary of Accsys Technologies PLC, and may not be used or reproduced without written permission from TWL, or in the case of the Tricoya® registered trademark, from Tricoya Technologies Limited, a subsidiary of TWL with exclusive rights to exploit the Tricoya® brand.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMOKKDQABKDQCB
Date   Source Headline
25th Jul 20147:00 amRNSDiamond Wood Licence Agreement
3rd Jul 20147:00 amRNSPreliminary results for the year ended March 2014
2nd Jul 20144:49 pmRNSNotifiable Interest
27th Jun 201412:00 pmRNSNotice of Results
2nd Jun 20147:00 amRNSMasisa Option Agreement Extended
7th May 20147:00 amRNSTrading Update
29th Apr 20147:05 amRNSNotice of Trading Update
29th Apr 20147:00 amRNSGordon Campbell CBE - Chairman
12th Feb 20147:47 amRNSReplacement: Interim Management Statement
12th Feb 20147:00 amRNSInterim Management Statement
31st Jan 201410:54 amRNSTotal Voting Rights
14th Jan 201411:01 amRNSAccsys Employee Share Participation Plan
10th Jan 20149:12 amRNSNotifiable Interest
23rd Dec 20137:00 amRNSACCOYA® LICENCE AGREEMENT WITH SOLVAY FORMALLY APP
25th Nov 20137:00 amRNSInterim Results
21st Nov 20133:01 pmRNSInterim results release date and webcast
20th Sep 20134:00 pmRNSLong Term Incentive Plan
19th Sep 20134:02 pmRNSAnnual General Meeting
19th Sep 20137:00 amRNSAGM Statement
30th Aug 20133:00 pmRNSTotal Voting Rights
28th Aug 20133:01 pmRNSNotice of AGM
16th Aug 20137:00 amRNSTermination of Diamond Wood licence agreement
1st Aug 20131:37 pmRNSAnnual Report and Financial Statements
1st Aug 20131:30 pmRNSTotal Voting Rights
30th Jul 20137:03 amRNSInterim Management Statement
23rd Jul 20133:59 pmRNSDirector/PDMR Shareholding
11th Jul 20137:00 amRNSAccsys JV signs Tricoya Licence Agreement
9th Jul 20131:25 pmRNSDirectors' Interests
28th Jun 20132:03 pmRNSNotifiable Interest
25th Jun 20137:00 amRNSAnnual Financial Report
21st Jun 20137:00 amRNSAnnual results release date and webcast
6th Jun 201310:17 amRNSAccsys joins the Social Stock Exchange
2nd May 20137:08 amRNSTrading update
14th Mar 20132:05 pmRNSDirector Information
20th Feb 201311:59 amRNSDirector's Interest
14th Feb 20137:04 amRNSInterim Management Statement
5th Feb 20134:40 pmRNSSecond Price Monitoring Extn
5th Feb 20134:35 pmRNSPrice Monitoring Extension
31st Jan 20139:02 amRNSTotal Voting Rights
25th Jan 20139:03 amRNSAnnual Information Update
16th Jan 20139:00 amRNSAccsys Employee Share Participation Plan
21st Nov 20128:13 amRNSInterim Results
16th Nov 20122:00 pmRNSInterim results release date and webcast
31st Oct 20124:16 pmRNSTotal Voting Rights
23rd Oct 201210:22 amRNSNotifiable Interest
23rd Oct 20129:17 amRNSPrestigous Awards and Certification
19th Oct 20127:07 amRNSAccsys-INEOS Tricoya(R) Joint Venture
8th Oct 20127:02 amRNSAccsys Completes Joint Venture With INEOS
1st Oct 20127:01 amRNSBoard Changes
28th Sep 20124:28 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.